Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.24.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income Statement [Abstract]        
Revenue, net $ 12,295 $ 9,078 $ 34,610 $ 29,931
Cost of revenue 4,789 4,124 13,602 12,163
Gross profit 7,506 4,954 21,008 17,768
Operating expenses:        
Sales and marketing 2,864 2,498 8,571 7,444
Research and development 199 149 483 484
General and administrative 2,538 2,124 6,918 7,515
Acquisition related amortization expense 199 834
Total operating expenses 5,601 4,970 15,972 16,277
Operating income (loss) from continuing operations 1,905 (16) 5,036 1,491
Interest accretion expense (4) (26) (34) (92)
Note payable interest (141) (230) (514) (682)
Other expense, net (394) (252) (406) (408)
Income (loss) from continuing operations before tax 1,366 (524) 4,082 309
Provision for income taxes 4 4 12 12
Income (loss) from continuing operations 1,362 (528) 4,070 297
Loss from discontinued operations, net of tax (82) (86) (260) (385)
Net income (loss) $ 1,280 $ (614) $ 3,810 $ (88)
Basic income (loss) per share of common stock:        
From continuing operations $ 0.31 $ (0.12) $ 0.93 $ 0.07
From discontinued operations (0.02) (0.02) (0.06) (0.09)
Net income (loss) per basic share of common stock 0.29 (0.14) 0.87 (0.02)
Diluted income (loss) per share of common stock:        
From continuing operations 0.31 (0.12) 0.92 0.07
From discontinued operations (0.02) (0.02) (0.05) (0.09)
Net income (loss) per diluted share of common stock $ 0.29 $ (0.14) $ 0.87 $ (0.02)
Weighted average number of common shares and common share equivalents outstanding:        
Basic 4,393 4,319 4,380 4,313
Diluted 4,423 4,319 4,404 4,355